Cancer

View All

The Business Cocktail
Inozyme Raises $67M; Shanghai Miracogen partners with Synaffix; EdiGENE raises $15M; Antengene announces its expansion

Inozyme Pharma Raises USD 67 Million in Series A2 Financing Inozyme Pharma- a Boston-based biotechnology company, solely focused on developing novel therapies to treat rare diseases, has raised USD 67 million. The company plans to use this funding to progress its lead asset INZ-701, into clinical trials. INZ-701...

Find More

Gene Therapy in Oncology
The promising Pipeline for Gene Therapy In Oncology

Gene therapy is a technique that involves replacing, inactivating, or adding a new gene to treat or prevent a disease. The science of GENE THERAPY involves the DNA-based changes in genetic material so that the gene can transcribe a healthy protein. In the past, there has been no success in designing any gene therap...

Find More

MEDICAL MARIJUANA
What can be the scope of Medical Marijuana?

What exactly is Marijuana? In a layman language, Marijuana is the dried buds and leaves of a plant Cannabis sativa favored in warm, wild tropical climates. Earning names like pot, ganja, weed, hemp, hash, etc. it contains around 104 active cannabinoids (CBD). What they do is, they mimic the signal producing che...

Find More

Multiple Sclerosis
Notizia

Selumetinib gets the U.S. Breakthrough Therapy Designation Selumetinib- an investigational drug, for the treatment of pediatric patients aged three years and above suffering from symptomatic and/or progressive, inoperable neurofibromatosis type 1 (NF1), plexiform neurofibromas (PN)- a rare genetic condition, has...

Find More

stem cell therapy
Notizia

Laminin might help to regenerate heart muscles Researchers at Duke-NUS Medical School, Singapore, have been studying the self-regeneration process of the heart. After an injury, the self- regeneration property of the heart has been limited. But now, Scientists turned to Stem Cell therapy. They are prepping stem ...

Find More

Notizia

Stemline gives in-licenses global rights to SL-1001 Stemline Therapeutics, Inc. is a biopharmaceutical company focused on development and commercialization of novel oncology therapeutics, has licensed worldwide rights to a preclinical molecule RET (rearranged during transfection) kinase inhibitor. The RET kinase...

Find More

cholangiocarcinoma
What is Cholangiocarcinoma (CCA)?

Cholangiocarcinoma (BILE Duct cancer) is a type of uncommon CANCER. It arises in Bile ducts. The Bile duct is a long tubule like structure which connects the liver (hepatic duct) to the gall bladder (cystic duct). It carries bile, which helps in digestion of food, from gall-bladder (produced in the liver) to inte...

Find More

Peloton Therapeutics
Peloton raises $150M; BiomX raises $32M; Abbott and Novo collaborate; Blaze Bioscience nets $5M

Peloton Therapeutics raises USD 150 Million for treating Advance Kidney Cancer Peloton Therapeutics has been in the process of developing small molecule drugs to treat Cancer, has raised USD 150 million. Peloton’s lead therapeutic candidate, PT2977, focuses on targeting hypoxia-inducible fac...

Find More

Kidney Cancer
Notizia

CRISPR treatment delivers benefits in mice The researchers from Duke University along with drugmaker Sarepta Therapeutics published a report stating that a single change in the genetic system of Duchenne muscular dystrophy (DMD) affected mice, using CRISPR gene editing tool resulted in increasing their life spa...

Find More

Virtual Reality Maps Helps Doctors Understand Cancer Tumor Structure

Doctors now have a new weapon in the fight against cancer: detailed maps of the cells in a tumour that can be explored and analyzed in a virtual reality simulation that its creators say provides researchers with an intuitive new way to examine complex medical data that could lead to unexpected breakthroughs. Bui...

Find More